BioTek Instruments Announces Establishment of Korean Office
News Mar 01, 2011
BioTek Korea will be fully functional by July 1, 2011. BioTek's long-time partner and distributor, DI Biotech, will work closely with BioTek Korea to ensure a seamless transition for the company's existing and expanding customer base.
"The establishment of BioTek Korea will allow BioTek to increase our investment of resources in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing incremental local service and application support, our customers in South Korea will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Korean customers."
The Role of Lung Cell Turnover in Influenze PneumoniaNews
Research led by University of Cincinnati scientists is investigating how influenza spreads through the lungs by focusing on how resistant or susceptible cells lining the airway are to viral infection.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE